FDA Investigator Yonggang Wang, PhD
Yonggang Wang, PhD has inspections in 5 countries as of 01 Sep 2023. Yonggang Wang, PhD has collaborated with a combined 1620 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
8
Last Inspection Date:
01 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Australia,
Austria,
Germany,
Belgium
Co-Investigator(s):
Ann M Stewart,
Ann Marie Montemurro,
Ann Marie Schofield,
Anthony F Lorenzo,
Ashley L Reiber,
Barbara M Frazier,
Bradley Dworak, PhD,
Brentley S Collins,
Brian D Nicholson,
Burnell M Henry,
Carrie Ann Plucinski,
CDR Donald Ertel,
CDR Jeremy L Wally, PhD,
Christian D Lynch (CDL),
Claire M Minden,
Cynthia Jim, CSO,
Daniel C Kearns,
David Galler Veety,
David Perkins,
Deborah M Trout,
Debra I Love,
Devaughn Edwards,
Dr. Andrew Shroke,
Dr. Gang Wang, PhD,
Eileen A Liu,
Eliezar Ramos,
Ewa Marszal, PhD,
Freddy Ortiz Colon,
Gene D Arcy,
Gregory Price,
Helen B Ricalde,
Holly Brevig,
Humera Khan,
Humera T Khan,
Irina Gaberman,
Jacqueline Mdiaz Albertini,
James R Evans,
Janet L Bowen,
Jason F Chancey,
Jeanne M Morris,
Jennifer L Schmidt,
Jie He,
Joan Johnson,
John M Seale,
Julie D Bringger,
Kula N Jha,
Laura Fontan, MS,
Laurel A Beer,
LCDR Debra Emerson,
LCDR Randall L Morris,
Lily Y Koo,
Linda Thai,
Lu Deng,
Malgorzata G Norton,
Mariza M Jafary,
Mary P Padgett,
Michael C Kennedy, PhD,
Michele Perry Williams,
Mihaly S Ligmond,
Mizanne E Lewis,
Nimmy Mathews,
Olga Simakova,
Omotunde O Osunsanmi,
Pankaj H Amin,
Parul M Patel,
Paula A Trost,
Prabhu P Raju,
Ralph A Erickson,
Randa Melhem, PhD,
Richard Heath Coats,
Richard T Riggie,
Robert C Coleman,
Robert W Jennings,
Roger F Zabinski,
Rose M Ashley,
Russell K Riley,
Samuel W Labinjo,
Sarah B Tanksley,
Scott T Ballard,
Sean R Bryd,
Sherry G Bous,
Sidney B Priesmeyer,
Siliva Wanis, PharmD,
Simone E Pitts,
Stephen D Brown,
Susan M Jackson,
Susan P Bruederle,
Timothy M Martin,
Unnee Ranjan,
Vioela J Caze,
Wei Wang, PhD,
Yvesna C Blaise,
Zainab Y Mansaray Storms
Yonggang Wang, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
November, 2019 | FDA 483 | CSL Behring (Australia) Pty Ltd - Form 483, 2019-11-11 |
October, 2018 | FDA 483 | CSL Behring L.L.C. - Form 483, 2018-10-18 |
March, 2018 | FDA 483 | Baxalta US Inc. - Form 483, 2018-03-02 |
August, 2018 | FDA 483 | Kedrion Biopharma Inc. - Form 483, 2018-08-29 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more